Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank postpones additional share issue for the acquisition of Home Bank to 2025

8/15/24 SVCB

X5 Retail Group reported for 6 months of 2024 by IFRS

8/15/24 X5

Delimobile opened new service stations

8/15/24 DELI

Sovcombank reported for 6 months of 2024 by IFRS

8/15/24 SVCB

Softline acquires control in one of Gazprombank's IT divisions

8/15/24 SOFL

Softline reported for 6 months of 2024 by IFRS

8/15/24 SOFL

VTB to join Post Bank in 2026

8/14/24 VTBR

Slavneft-Megionneftegaz reported for 6M 2024 by RAS

8/14/24 MFGS

Moscow Exchange resumes trading on the stock market

8/14/24 MOEX

Trading on the stock market has been suspended

8/14/24 MOEX